Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.

De Andrade JP, Lorenzen AW, Wu VT, Bogachek MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ.

Oncotarget. 2017 Oct 23;8(70):114801-114815. doi: 10.18632/oncotarget.21954. eCollection 2017 Dec 29.

2.

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.

Arildsen NS, Jönsson JM, Bartuma K, Ebbesson A, Westbom-Fremer S, Måsbäck A, Malander S, Nilbert M, Hedenfalk IA.

Front Oncol. 2017 May 29;7:109. doi: 10.3389/fonc.2017.00109. eCollection 2017.

3.

Role of retinoids in the prevention and treatment of colorectal cancer.

Applegate CC, Lane MA.

World J Gastrointest Oncol. 2015 Oct 15;7(10):184-203. doi: 10.4251/wjgo.v7.i10.184. Review.

4.

CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.

Liu RZ, Garcia E, Glubrecht DD, Poon HY, Mackey JR, Godbout R.

Mol Cancer. 2015 Jul 5;14:129. doi: 10.1186/s12943-015-0380-7.

5.

miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.

Bhattacharya A, Schmitz U, Raatz Y, Schönherr M, Kottek T, Schauer M, Franz S, Saalbach A, Anderegg U, Wolkenhauer O, Schadendorf D, Simon JC, Magin T, Vera J, Kunz M.

Oncotarget. 2015 Feb 20;6(5):2966-80.

6.

Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Dearth RK, Hiney JK, Srivastava VK, Hamilton AM, Dees WL.

Exp Biol Med (Maywood). 2014 Jul;239(7):871-882. Epub 2014 May 20.

7.

Sumoylation pathway is required to maintain the basal breast cancer subtype.

Bogachek MV, Chen Y, Kulak MV, Woodfield GW, Cyr AR, Park JM, Spanheimer PM, Li Y, Li T, Weigel RJ.

Cancer Cell. 2014 Jun 16;25(6):748-61. doi: 10.1016/j.ccr.2014.04.008. Epub 2014 May 15.

8.

TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.

Fu L, Shi K, Wang J, Chen W, Shi D, Tian Y, Guo W, Yu W, Xiao X, Kang T, Wang S, Huang W, Deng W.

Mol Cancer. 2014 Apr 26;13:89. doi: 10.1186/1476-4598-13-89.

9.

Melanoma: from melanocyte to genetic alterations and clinical options.

Bertolotto C.

Scientifica (Cairo). 2013;2013:635203. doi: 10.1155/2013/635203. Epub 2013 Dec 12. Review.

10.

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.

Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, Wang X, Eldridge RC, Tessier DC, Vincent D, Bacot F, Hogervorst FB, Peock S, Stoppa-Lyonnet D; KConFab Investigators, Peterlongo P, Schmutzler RK, Nathanson KL, Piedmonte M, Singer CF, Thomassen M; Ontario Cancer Genetics Network, Hansen Tv, Neuhausen SL, Blanco I, Greene MH, Garber J, Weitzel JN, Andrulis IL, Goldgar DE, D'Andrea E, Caldes T, Nevanlinna H, Osorio A, van Rensburg EJ, Arason A, Rennert G, van den Ouweland AM, van der Hout AH, Kets CM, Aalfs CM, Wijnen JT, Ausems MG; HEBON; EMBRACE, Frost D, Ellis S, Fineberg E, Platte R, Evans DG, Jacobs C, Adlard J, Tischkowitz M, Porteous ME, Damiola F; GEMO Study Collaborators, Golmard L, Barjhoux L, Longy M, Belotti M, Ferrer SF, Mazoyer S, Spurdle AB, Manoukian S, Barile M, Genuardi M, Arnold N, Meindl A, Sutter C, Wappenschmidt B, Domchek SM, Pfeiler G, Friedman E, Jensen UB, Robson M, Shah S, Lazaro C, Mai PL, Benitez J, Southey MC, Schmidt MK, Fasching PA, Peto J, Humphreys MK, Wang Q, Michailidou K, Sawyer EJ, Burwinkel B, Guénel P, Bojesen SE, Milne RL, Brenner H, Lochmann M; GENICA Network, Aittomäki K, Dörk T, Margolin S, Mannermaa A, Lambrechts D, Chang-Claude J, Radice P, Giles GG, Haiman CA, Winqvist R, Devillee P, García-Closas M, Schoof N, Hooning MJ, Cox A, Pharoah PD, Jakubowska A, Orr N, González-Neira A, Pita G, Alonso MR, Hall P, Couch FJ, Simard J, Altshuler D, Easton DF, Chenevix-Trench G, Antoniou AC, Offit K.

PLoS Genet. 2013;9(3):e1003173. doi: 10.1371/journal.pgen.1003173. Epub 2013 Mar 27.

11.

Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.

Kulak MV, Cyr AR, Woodfield GW, Bogachek M, Spanheimer PM, Li T, Price DH, Domann FE, Weigel RJ.

Oncogene. 2013 Aug 22;32(34):4043-51. doi: 10.1038/onc.2012.400. Epub 2012 Sep 10.

12.

Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2.

Bochkis IM, Schug J, Ye DZ, Kurinna S, Stratton SA, Barton MC, Kaestner KH.

PLoS Genet. 2012;8(6):e1002770. doi: 10.1371/journal.pgen.1002770. Epub 2012 Jun 21.

13.

Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.

Kerschgens J, Renaud S, Schütz F, Grasso L, Egener-Kuhn T, Delaloye JF, Lehr HA, Vogel H, Mermod N.

PLoS One. 2011;6(8):e22895. doi: 10.1371/journal.pone.0022895. Epub 2011 Aug 18.

14.

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.

Nordentoft I, Dyrskjøt L, Bødker JS, Wild PJ, Hartmann A, Bertz S, Lehmann J, Orntoft TF, Birkenkamp-Demtroder K.

BMC Cancer. 2011 Apr 14;11:135. doi: 10.1186/1471-2407-11-135.

15.

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.

Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, Tombolini V.

Mol Cancer. 2010 Nov 25;9:305. doi: 10.1186/1476-4598-9-305. Review.

16.

Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter.

Scibetta AG, Wong PP, Chan KV, Canosa M, Hurst HC.

Cell Cycle. 2010 Nov 15;9(22):4525-32.

17.

CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Melnikova VO, Dobroff AS, Zigler M, Villares GJ, Braeuer RR, Wang H, Huang L, Bar-Eli M.

PLoS One. 2010 Aug 27;5(8):e12452. doi: 10.1371/journal.pone.0012452.

18.

Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.

Woodfield GW, Chen Y, Bair TB, Domann FE, Weigel RJ.

Genes Chromosomes Cancer. 2010 Oct;49(10):948-62. doi: 10.1002/gcc.20807.

19.

Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes.

Orso F, Corà D, Ubezio B, Provero P, Caselle M, Taverna D.

BMC Genomics. 2010 Jun 3;11:355. doi: 10.1186/1471-2164-11-355.

20.

Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.

Thewes V, Orso F, Jäger R, Eckert D, Schäfer S, Kirfel G, Garbe S, Taverna D, Schorle H.

BMC Cancer. 2010 May 11;10:192. doi: 10.1186/1471-2407-10-192.

Supplemental Content

Support Center